Medications

US approves pricey new pill against hepatitis C

US regulators on Friday approved Harvoni, a daily pill to treat hepatitis C that is simpler to administer than long-standing treatments but that carries a steep price tag.

Medications

Safety advocates seek stronger warnings on Chantix (Update)

Public safety advocates are asking the federal government to strengthen warnings on Pfizer's anti-smoking drug Chantix, even as the drugmaker prepares to argue that a bold-letter warning about psychiatric problems should ...

Medications

Certain meds, driving can be deadly mix: FDA

(HealthDay News) —Thinking about taking a drive after popping some over-the-counter medications? Better check the label first, warn experts at the U.S. Food and Drug Administration.

Neuroscience

US aims for traumatic brain injury clinical trial success

An unprecedented, public-private partnership funded by the Department of Defense (DoD) is being launched to drive the development of better-run clinical trials and may lead to the first successful treatments for traumatic ...

Medications

New FDA label bolsters safety case for Chantix

New government-approved labeling on Pfizer's drug Chantix suggests that the anti-smoking medication may not carry the risks of suicidal behavior that first earned it the Food and Drug Administration's strongest warning more ...

Medications

Anti-addiction groups call for new FDA chief

Anti-addiction activists are calling for the Food and Drug Administration's top official to step down, saying the agency's policies have contributed to a national epidemic of prescription painkiller abuse.

Medications

Blood test for yeast infections approved

(HealthDay)—The first blood test to detect five strains of yeast that cause rare blood infections in people with weakened immune systems has been approved by the U.S. Food and Drug Administration.

page 17 from 40